|16 January, 2020

Fakih IVF welcomed over 8,000 patients with high success rates

Providing a diverse line-up of services that increases chances of conception

Fakih IVF welcomed over 8,000 patients with high success rates

Dubai United Arab Emirates:( AETOSWire)-- Fakih IVF, one of the leading infertility centers in the GCC welcomed over 8,000 patients in the past year, demonstrating a success rate of 65%. To further extend their support to individuals battling infertility, the fertility center is running a campaign “New Year, New beginnings and a new chance at parenthood” with a hope of raising public awareness and educating individuals about the various treatment options available to better address this issue.

Through the month of January, Fakih IVF will be providing free consultation to all new and old fertility patients. Substantial discounts can also be availed on IVF-ICSI packages all month long. The aim is to reach out to all couples trying to conceive by extending the best possible support to them.

Dr Michael Fakih, Medical Director of Fakih IVF Group said, “With centers across UAE and abroad Fakih IVF provides a variety of assisted reproductive treatments which allows us to cater to the diverse requirements of our patients. We are dedicated to providing couples with all of the tools available to aid them in fulfilling their dreams of parenthood. Our fertility experts study a patient’s entire medical history to decide the best course of treatment for them.”

Infertility is on a rise these days and it is essential for patients to seek proper medical intervention from industry experts so that they understand the ideal course of action. Patients are also recommended to follow a healthy diet and completely eliminate the intake of caffeine and alcohol.

Fakih IVF Fertility Center is one of the leading Infertility, Gynecology, Obstetrics, Genetics and IVF centers in the GCC region with centers in Abu Dhabi, Al Ain and Dubai. With several state-of-the-art technologies, the center is continually advancing in the field of reproductive medicine across the region.

*Source: AETOSWire

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases